Paul W. Hoelscher - 28 Dec 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
EVP, CFO
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Dec 2021
Net transactions value
-$806,393
Form type
4
Filing time
30 Dec 2021, 20:00:16 UTC
Previous filing
30 Jul 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Gift $0 -6,163 -75% $0.000000 2,098 25 Aug 2021 Direct
transaction HZNP Ordinary Shares Gift $0 +6,163 +3.6% $0.000000 178,389 25 Aug 2021 By Trust
transaction HZNP Ordinary Shares Gift $0 -1,049 -50% $0.000000 1,049 03 Dec 2021 Direct
transaction HZNP Ordinary Shares Options Exercise $136,857 +8,575 +817% $15.96* 9,624 28 Dec 2021 Direct
transaction HZNP Ordinary Shares Sale $943,250 -8,575 -89% $110.00 1,049 28 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -8,575 -13% $0.000000 56,365 28 Dec 2021 Ordinary Shares 8,575 $15.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
F2 The option is fully vested and exercisable.